Showing results (101-110 of 458) with videos related to
Sort By:
Pageof 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Gene expression profiling of the irinotecan pathway in colorectal cancerJinsheng Yu, William D Shannon, Mark A Watson, et al.Journal of Clinical Pharmacology|April 9, 2002
Pharmacokinetic study of infusional valspodarMargaret K Ma, Howard L McLeod, Peter Westervelt, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 1, 2022
Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelinesDaryl Pritchard, Jai N Patel, Lindsay E Stephens, et al.BMC Cancer|March 29, 2018
Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer's perspectivePing-Tee Tan, Mohamed Ismail Abdul Aziz, Fiona Pearce, et al.Critical Reviews in Oncology/Hematology|November 27, 2009
Impact of comorbidities on clinical outcomes in non-small cell lung cancer patients who are elderly and/or have poor performance statusJoanne Ngeow, Swan Swan Leong, Fei Gao, et al.Methods in Molecular Biology (Clifton, N.J.)|August 16, 2005
Pyrosequencing of clinically relevant polymorphismsSharon Marsh, Cristi R King, Adam A Garsa, et al.Human Mutation|May 18, 2004
PromoLign: a database for upstream region analysis and SNPsTao Zhao, Li-Wei Chang, Howard L McLeod, et al.Journal of Cardiac Failure|April 3, 2012
Genetic tailoring of pharmacotherapy in heart failure: optimize the old, while we wait for something newJasmine A Talameh, Howard L McLeod, Kirkwood F Adams, et al.Frontiers in Public Health|December 19, 2022
Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypesXin Yin, Gillianne Geet Yi Lai, Adeline Seow, et al.Genetic Epidemiology|July 10, 2008
CANDID: a flexible method for prioritizing candidate genes for complex human traitsJanna E Hutz, Aldi T Kraja, Howard L McLeod, et al.Pageof 46